What is King Pharmaceuticals's long-term investments?

King Pharmaceuticals (KG) reported long-term investments of $339.34M in Q1 2026.

What does long-term investments mean?

Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.

King Pharmaceuticals KG Long-term investments

Long-term investments at other companies

Arch Capital GroupACGL

$46.79B+11.1%

SiriusPointSPNT

$5.31B+3.7%

Skyward Specialty Insurance Group, Inc.SKWD

$2.74B+37.7%

Selective Insurance GroupSIGI

$11.39B+10.6%

Reinsurance Group of AmericaRGA

$137.01B+29.8%

W.R. BerkleyWRB

$31.29B+8.6%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Investments.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's long-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's long-term investments?: King Pharmaceuticals (KG) reported long-term investments of $339.34M in Q1 2026.
What does long-term investments mean?: Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.